138 related articles for article (PubMed ID: 34250549)
1. Aniseikonia following intravitreal ranibizumab treatment for branch retinal vein occlusion.
Morikawa S; Okamoto F; Murakami T; Sugiura Y; Hiraoka T; Oshika T
Jpn J Ophthalmol; 2021 Sep; 65(5):672-679. PubMed ID: 34250549
[TBL] [Abstract][Full Text] [Related]
2. Stereopsis after Intravitreal Ranibizumab Injections for Branch Retinal Vein Occlusion.
Morikawa S; Okamoto F; Sugiura Y; Murakami T; Hiraoka T; Oshika T
Ophthalmol Retina; 2019 Sep; 3(9):777-783. PubMed ID: 31155472
[TBL] [Abstract][Full Text] [Related]
3. Time course of changes in contrast sensitivity following intravitreal ranibizumab injection for branch retinal vein occlusion.
Sugiura Y; Okamoto F; Murakami T; Morikawa S; Hiraoka T; Oshika T
Jpn J Ophthalmol; 2020 Sep; 64(5):497-505. PubMed ID: 32691257
[TBL] [Abstract][Full Text] [Related]
4. Visual functions affecting stereopsis in patients with branch retinal vein occlusion.
Morikawa S; Okamoto F; Murakami T; Sugiura Y; Hiraoka T; Oshika T
Eye (Lond); 2022 Feb; 36(2):457-462. PubMed ID: 33707764
[TBL] [Abstract][Full Text] [Related]
5. TIME COURSE OF CHANGES IN METAMORPHOPSIA FOLLOWING INTRAVITREAL RANIBIZUMAB INJECTION FOR BRANCH RETINAL VEIN OCCLUSION.
Sugiura Y; Okamoto F; Morikawa S; Okamoto Y; Hiraoka T; Oshika T
Retina; 2018 Aug; 38(8):1581-1587. PubMed ID: 28614133
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.
Shiono A; Kogo J; Sasaki H; Yomoda R; Jujo T; Tokuda N; Kitaoka Y; Takagi H
PLoS One; 2018; 13(6):e0199552. PubMed ID: 29924853
[TBL] [Abstract][Full Text] [Related]
7. Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.
Winterhalter S; Eckert A; Vom Brocke GA; Schneider A; Pohlmann D; Pilger D; Joussen AM; Rehak M; Grittner U
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):267-279. PubMed ID: 29185099
[TBL] [Abstract][Full Text] [Related]
8. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
10. Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.
Tadayoni R; Waldstein SM; Boscia F; Gerding H; Pearce I; Priglinger S; Wenzel A; Barnes E; Gekkieva M; Pilz S; Monés J;
Ophthalmology; 2016 Jun; 123(6):1332-44. PubMed ID: 27039022
[TBL] [Abstract][Full Text] [Related]
11. Relationship between metamorphopsia and inner retinal microstructure following intravitreal ranibizumab injection for branch retinal vein occlusion.
Sugiura Y; Okamoto F; Murakami T; Morikawa S; Hiraoka T; Hussnain SA; Oshika T
Sci Rep; 2021 Feb; 11(1):4454. PubMed ID: 33627734
[TBL] [Abstract][Full Text] [Related]
12. Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study.
Minami Y; Nagaoka T; Ishibazawa A; Yoshida A
BMC Ophthalmol; 2017 Jun; 17(1):90. PubMed ID: 28610573
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion.
Çakmak HB; Arikan Yorgun M; Toklu Y; Mutlu M
Turk J Med Sci; 2017 Feb; 47(1):40-46. PubMed ID: 28263518
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
16. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T
Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
18. Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy.
Suzuki M; Nagai N; Minami S; Kurihara T; Kamoshita M; Sonobe H; Watanabe K; Shinoda H; Tsubota K; Ozawa Y
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):49-56. PubMed ID: 31732812
[TBL] [Abstract][Full Text] [Related]
19. EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial Data.
Bell KJ; Hayen A; Glasziou P; Mitchell AS; Farris M; Wright J; Duerr HP; Mitchell P; Irwig L
Retina; 2017 Mar; 37(3):509-514. PubMed ID: 27548351
[TBL] [Abstract][Full Text] [Related]
20. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
Song S; Yu X; Zhang P; Gu X; Dai H
BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
